非妇科细胞病理学外部质量保证:澳大利亚亚地区经验
澳大利亚皇家病理学家学院细胞病理学质量保证项目自1993年起向16个国家约200个实验室分发非妇科玻璃幻灯片。研究回顾了123例非妇科病例的超过22000份结果,发现浆膜腔积液转移性癌、高分化癌、尿标本少量恶性细胞、支气管肺泡灌洗反应性肺泡细胞、乳腺乳头状病变等诊断困难,而肺和甲状腺FNA(尤其甲状腺乳头状癌)报告良好。
要点
- 浆膜腔积液分散型转移癌、高分化癌及细胞丰富反应性病例诊断难度大。
- 尿标本少量恶性细胞、支气管肺泡灌洗反应性肺泡细胞易误诊。
- 乳腺FNA乳头状病变、妊娠标本及纤维腺瘤诊断困难。
核心结论
- 非妇科细胞病理学外部质量保证项目通过多制片同一标本实现实验室间比较,兼具教育和认证作用。
研究设计与样本
- 澳大利亚皇家病理学家学院细胞病理学质量保证项目自1993年起向16个国家约200个实验室分发非妇科玻璃幻灯片。
- 研究回顾了123例非妇科病例的超过22000份结果。
主要发现
- 诊断最困难的病例包括浆膜腔积液分散型转移癌、高分化癌及细胞丰富反应性病例。
- 尿标本少量恶性细胞、支气管肺泡灌洗反应性肺泡细胞、乳腺FNA乳头状病变、妊娠标本及纤维腺瘤诊断困难。
- 肺和甲状腺FNA(尤其甲状腺乳头状癌)通常报告良好。
临床怎么用
- 实验室可参考诊断困难病例类型加强判读培训与质控。
- 同一标本多制片有助于实验室间结果比较和持续改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Royal College of Pathologists of Australasia Cytopathology Quality Assurance Program has operated an external quality assurance program in nongynecologic cytopathology since 1993. Glass slide preparations of a wide range of nongynecologic cases were circulated to approximately 200 cytopathology laboratories in 16 countries. METHODS: General nongynecologic cytology cases were manufactured from residual specimens after routine diagnosis. Fine-needle aspiration (FNA) cases were made by sampling fresh tissue and making direct specimens. The majority of cases consisted of both air-dried and fixed preparations. Results returned to laboratories included illustrated case discussions highlighting diagnostic features, key differential diagnoses, and useful adjunctive tests. RESULTS: The current study reviewed >22,000 results for 123 nongynecologic cases. Cases found to cause the most diagnostic difficulties included serous effusion cases with metastatic carcinoma in a dispersed pattern, well-differentiated carcinoma, and cellular reactive cases; urine specimens with sparse malignant cells; reactive pneumocytes in a bronchoalveolar lavage; breast FNA cases with papillary lesions; gestational specimens; and fibroadenoma. FNA specimens from the lung and thyroid, particularly papillary thyroid carcinoma, generally were well reported. CONCLUSIONS: The use of multiple preparations of the same specimen has allowed interlaboratory comparison, and the quality assurance program has played an educational role as well as informing the laboratory accreditation process. Cancer Cytopathol 2017;125:349-361. © 2017 American Cancer Society.
引用
- Shield PW, Frost F, Finnimore JL, et al. External quality assurance in nongynecologic cytology: The Australasian experience. Cancer Cytopathol. 2017. PMID: 28241108. doi:10.1002/cncy.21838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。